Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Increased risk of ankylosing spondylitis after Mycoplasma pneumonia: A Nationwide population-based study
Kuo-An Chu1,2,3, Weishan Chen4,5, Yao-Min Hung3,6,7
1Division of Chest Medicine, Department of Internal Medicine, Kaohsiung Veterans General Hospital.
Abstract:
This study aimed to investigate the relationship between Mycoplasma pneumonia (MP) infection and new development of ankylosing spondylitis (AS).Using data from the Taiwan National Health Insurance Research Database, we included a total of 116,084 patients with newly diagnosed MP between 2000 and 2012. The control cohort consisted of patients who did not have MP, matched 1:4 by age, sex, and index year. The follow-up period was defined as the time from the initial diagnosis of MP to the date of diagnosis of AS, censoring, or 31 December 2013. Cox proportional hazards regression analysis was used to analyze the risk of autoimmune diseases by sex, age, and comorbidities, with hazard ratios (HRs) and 95% confidence intervals (CIs).The eligible study participants included 116,084 patients in the MP group and 464,336 patients in the comparison group. The incidence rates of AS in the MP group and comparison groups were 1.49 and 0.74 per 1,000,000-person years, respectively. The adjusted HR of AS for the MP group was 2.45 (95% CI = 1.02-5.90) compared to the control group after adjustment for age, sex, and all covariates.MP remained an independent risk factor for developing AS in terms of sex, age, and comorbidities.
Insights
Mycoplasma pneumonia (MP) infection is linked to an increased risk of developing ankylosing spondylitis (AS). This study found MP to be an independent risk factor for AS development.
Area of Science:
- Rheumatology
- Infectious Diseases
- Epidemiology
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease.
- The role of infections, such as Mycoplasma pneumonia (MP), in AS pathogenesis requires further investigation.
Purpose of the Study:
- To examine the association between Mycoplasma pneumonia (MP) infection and the subsequent development of ankylosing spondylitis (AS).
Main Methods:
- A population-based cohort study using the Taiwan National Health Insurance Research Database.
- 116,084 patients with newly diagnosed MP were compared to 464,336 controls.
- Cox proportional hazards regression analysis was employed to assess AS risk, adjusting for covariates.
Main Results:
- The incidence of AS was higher in the MP group (1.49 per 1,000,000 person-years) compared to the control group (0.74 per 1,000,000 person-years).
- Patients with MP had an adjusted Hazard Ratio of 2.45 (95% CI: 1.02-5.90) for developing AS.
- MP was identified as an independent risk factor for AS.
Conclusions:
- Mycoplasma pneumonia infection is associated with an increased risk of developing ankylosing spondylitis.
- MP may play a role in the etiology or trigger of AS.
Related Concept Videos
Conservation of Small Populations
Population Growth
What is Population Genetics?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
What are Populations and Communities?

